Dr. Reddy's Laboratories is a pharmaceutical company. Co.'s segments include: Global Generics, which includes its business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which includes its business of manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which includes its business that focuses on the research and development of differentiated formulations. When considering the Dr. Reddy's Laboratories Ltd. stock dividend history, we have taken known splits into account, such that the RDY dividend history is presented on a split-adjusted ("apples to apples") basis. Dr. Reddy's Laboratories Ltd. dividend history is presented both in graphical/chart form, and as a RDY dividend history data table along the right-hand column.
|
RDY Stock Dividend HistoryThe RDY dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable RDY historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the RDY dividend history record. Also see the RDY stock dividend history data table along the right-hand column below. |
|
|
Hold (2.25 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: RDY Forecast Based on data provided by Zacks Investment Research via Quandl.com |